Projects per year
Organization profile
Organisation profile
This doctoral research program was established in collaboration with Academia Sinica to cultivate interdisciplinary research that focuses on tumor-related medicine. Academia Sinica is Taiwan’s leading research institute and has outstanding scientific researchers and cutting-edge equipment for advanced research. TMU also works in collaboration with its three affiliated hospitals and has access to their clinical resources.
Through these relationships, the Cancer Biology and Drug Discovery program offers students a great opportunity to build a career with excellent research support. We enroll top students from around the world, and provide a strong curriculum of interdisciplinary training as well as a learning environment where students work with many research specialists.
From basic research to translational medicine, we develop cutting-edge therapeutic strategies for cancer prevention and treatment. We work hard for cancer patients, seeking to extend their lives and improve their quality of life.
Fingerprint
Dive into the research topics where Ph.D. Program for Cancer Molecular Biology and Drug Discovery is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Cheng-Kuei Chang
- Graduate Institute of Injury Prevention and Control - Professor
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery - Joint-Appointment Professor
- Taipei Medical University Shuang Ho Hospital - Visiting Staff
Person: Researcher
-
Chi-Long Chen
- Department of Pathology - Professor
- Graduate Institute of Clinical Medicine - Joint-Appointment Professor
- International Master/Ph.D. Program in Medicine - Joint-Appointment Professor
- Professional Master Program in Artificial Intelligence in Medicine - Joint-Appointment Professor
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery - Joint-Appointment Professor
- Taipei Medical University Hospital - Visiting Staff
- TMU Research Center of Cancer Translational Medicine - Member
- Research Center for Artificial Intelligence in Medicine, Taipei Medical University - Member
Person: Researcher
-
Hsin-Yi Chen
- Master Program in Graduate Institute of Cancer Biology and Drug Discovery - Associate Professor
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery - Joint-Appointment Associate Professor
- TMU Research Center of Cancer Translational Medicine - Member
Person: Researcher
-
探討TEAD4調控粒線體活性及引發攝護腺癌症的機制(1/5)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
研究介白素-1受體拮抗劑(IL1RN)在胰臟癌的功能(1/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
標靶整合素αvβ3-FAK訊號網絡的膽管癌診療策略開發-以PRS技術平台優化膽管癌的組合療法(1/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
Research output
-
2,3,5,4′-Tetrahydroxystilbene-2-O-β-d-glucoside promotes the effects of dental pulp stem cells on rebuilding periodontal tissues in experimental periodontal defects
Lin, C. Y., Tsai, M. S., Kuo, P. J., Chin, Y. T., Weng, I. T., Wu, Y., Huang, H. M., Hsiung, C. N., Lin, H. Y. & Lee, S. Y., Feb 2021, In: Journal of Periodontology. 92, 2, p. 306-316 11 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
An annotation-free whole-slide training approach to pathological classification of lung cancer types using deep learning
Chen, C. L., Chen, C. C., Yu, W. H., Chen, S. H., Chang, Y. C., Hsu, T. I., Hsiao, M., Yeh, C. Y. & Chen, C. Y., Feb 19 2021, In: Nature Communications. 12, 1, p. 1193 1193.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
An integrated bioinformatics study of a novel niclosamide derivative, nsc765689, a potential gsk3β/β-catenin /stat3/ cd44 suppressor with anti-glioblastoma properties
Mokgautsi, N., Wen, Y. T., Lawal, B., Khedkar, H., Sumitra, M. R., Wu, A. T. H. & Huang, H. S., Mar 1 2021, In: International journal of molecular sciences. 22, 5, p. 1-23 23 p., 2464.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus)
Datasets
-
Additional file 2: of Radix Paeoniae Rubra stimulates osteoclast differentiation by activation of the NF-ÎşB and mitogen-activated protein kinase pathways
Tzeng, H. (Contributor), Tsai, C. (Contributor), Ho, T. (Contributor), Hsieh, C. (Contributor), Chou, S. (Contributor), Lee, Y. (Contributor), Tsay, G. (Contributor), Huang, P. (Contributor) & Wu, Y. (Contributor), Unknown Publisher, Apr 23 2018
DOI: 10.6084/m9.figshare.6175154.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Radix_Paeoniae_Rubra_stimulates_osteoclast_differentiation_by_activation_of_the_NF-_B_and_mitogen-activated_protein_kinase_pathways/6175154/1
Dataset
-
Signaling in and out: long-noncoding RNAs in tumor hypoxia
Kuo, T. (Contributor), Kung, H. (Contributor) & Shih, J. (Contributor), Unknown Publisher, May 5 2020
DOI: 10.6084/m9.figshare.c.4966148.v1, https://doi.org/10.6084%2Fm9.figshare.c.4966148.v1
Dataset
-
Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology
Lee, Y. (Contributor), Huang, W. (Contributor), Lin, J. (Contributor), Kao, T. (Contributor), Lin, H. (Contributor), Lee, K. (Contributor), Lin, H. (Contributor), Shen, C. (Contributor), Chang, W. (Contributor) & Huang, C. (Contributor), Unknown Publisher, Nov 8 2018
DOI: 10.6084/m9.figshare.c.4294289.v1, https://figshare.com/collections/Znf179_E3_ligase-mediated_TDP-43_polyubiquitination_is_involved_in_TDP-43-_ubiquitinated_inclusions_UBI_-related_neurodegenerative_pathology/4294289/1
Dataset